John C. Byrd MD

Summary

• I am currently Chair, Department of Internal Medicine at the University of Cincinnati and also a physician scientist who has done translational and clinical drug development for two decades. Closest to me professional being is performing as an exceptional, empathetic board certified hematologist in care of patients with blood cancers. My laboratory and clinical research has directly resulted in 7 drugs getting FDA approval. This experience bridges close interaction with industry as a consultant to develop and implement a successful development plan (Calistoga, Idelalisib) to performing pre-clinical and clinical work in my University role focused on a single class of drugs that transformed the care of CLL (Ibrutinib, Acalabrutinib) and other B-cell malignancies. My role in the current Leukemia and Lymphoma Society Beat AML Study as Principal and Chief Medical Officer has offered an even larger extension of this by planning, implementing, and running a multi-center umbrella study in AML that brings together academic clinical investigators, diagnostic companies, pharmaceutical companies, clinical research organizations and the FDA to effectively move new therapies forward to the clinic.